BHVN
Biohaven Ltd.
13.70$
-7.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -31.5% | – | – | – | – | |
| – | – | – | – | 0.3% | – | – | – | – | |
| – | – | – | – | 14.2% | – | – | – | – | |
| – | – | – | – | 27.8% | – | – | – | – | |
| – | – | – | – | 0.4% | – | – | – | – | |
| – | – | – | – | 0.2% | – | – | – | – | |
| – | – | – | – | 0.2% | – | – | – | – | |
| – | – | – | – | 74.7% | – | – | – | – | |
| – | – | – | – | 90.9% | – | – | – | – | |
| – | – | – | – | 29.9% | – | – | – | – | |
| – | – | – | – | -1.4% | – | – | – | – | |
| – | – | – | – | -31.7% | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.